MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q1
hinzugefügt 09.05.2024
Alpine Immune Sciences EV 2011-2026 | ALPN
EV Jährlich Alpine Immune Sciences
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 363 M | 277 M | 291 M | 63.4 M | 91.7 M | 70.2 M | 15.9 M | 23.4 M | 16.5 M | 94.3 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 363 M | 15.9 M | 131 M |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M |  USA |
 |
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.68 | 2.44 % | $ 429 M |  Britain |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M |  Canada |
 |
Adverum Biotechnologies
ADVM
|
125 M | - | - | $ 86.2 M | USA |
 |
Kamada Ltd.
KMDA
|
252 M | $ 8.81 | 1.73 % | $ 260 M |  Israel |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
-23.2 M | - | - | $ 1.01 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Adagene
ADAG
|
395 M | $ 3.26 | 0.62 % | $ 183 M | China |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.28 | -2.62 % | $ 7.89 B |  Australia |
 |
Evogene Ltd.
EVGN
|
9.72 M | $ 0.81 | -9.28 % | $ 27.9 M | Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Nymox Pharmaceutical Corporation
NYMX
|
145 M | - | -19.68 % | $ 18.4 M | Canada |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Aptorum Group Limited
APM
|
9.45 M | $ 0.79 | -1.29 % | $ 4.31 M | China |
 |
AlloVir
ALVR
|
-64.1 M | - | 4.14 % | $ 49.1 M | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
5.47 M | $ 0.88 | -1.43 % | $ 442 M | Israel |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M | Canada |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Ascendis Pharma A/S
ASND
|
849 M | $ 224.42 | -2.52 % | $ 5 B |  Danmark |
 |
Applied Genetic Technologies Corporation
AGTC
|
-9.16 M | - | - | $ 26.5 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
5.65 B | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-37.4 M | - | 3.77 % | $ 22.4 M | USA |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Anavex Life Sciences Corp.
AVXL
|
197 M | $ 4.13 | 0.12 % | $ 352 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | USA |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.36 | 2.27 % | $ 14.8 M | USA |
 |
Aptinyx
APTX
|
-18.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
AstraZeneca PLC
AZN
|
57.7 B | - | - | $ 96.9 B | Britain |
 |
Aridis Pharmaceuticals
ARDS
|
38.2 M | - | 17.91 % | $ 11.1 M | USA |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Codexis
CDXS
|
354 M | $ 1.17 | -0.85 % | $ 85.9 M | USA |
 |
Athira Pharma
ATHA
|
-18.3 M | - | - | $ 269 M | USA |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 110.12 | -0.28 % | $ 27.2 B | Germany |
 |
Amneal Pharmaceuticals
AMRX
|
1.72 B | $ 14.49 | -0.75 % | $ 4.48 B | USA |
 |
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |